A network pharmacology method explores the molecular mechanism of Coptis chinensis for the treatment of Alzheimer's disease.
Network pharmacology predicted molecular mechanisms of Coptis chinensis in Alzheimer's treatment, revealing active ingredients, targets, and a drug-component-disease-target network. Main signaling pathways involved PI3K-Akt, AGE-RAGE, MAPK, HIF-1, TNF, and relaxin. Berberine demonstrated strong affinity, informing future clinical research.
- Qian Q and Luo WL (2024).
- Medicine (Baltimore).
- PubMed:
- 38306514